Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore optimal dosing strategies for adoptive cell therapies in non-small cell lung cancer (NSCLC) through this 14-minute conference talk that applies agent-based modeling to evolutionary immunotherapy approaches. Learn how mathematical oncology principles can be used to identify the most effective dosing protocols for adoptive cell therapies, examining the evolutionary dynamics between cancer cells and therapeutic immune cells. Discover how computational modeling techniques can inform clinical decision-making in immunotherapy treatment planning, with specific focus on optimizing therapeutic outcomes while minimizing potential resistance development in NSCLC patients.
